Wael Alqarawi
Overview
Explore the profile of Wael Alqarawi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alarify G, Alrumaih L, Qetab S, Alqarawi W
J Saudi Heart Assoc
. 2024 Oct;
36(3):301-304.
PMID: 39468999
A 33-year-old female with recurrent syncope episodes showed normal ECG and Holter results, but had mitral valve prolapse (MVP) with moderate mitral regurgitation (MR) on an echocardiogram. Cardiovascular magnetic resonance...
2.
Alqarawi W, Allwaim M
Front Cardiovasc Med
. 2024 Oct;
11:1465264.
PMID: 39450233
Background: Corrected QT (QTc) is an important electrocardiographic (ECG) interval. Physicians rely on automated QTc provided by ECG machines while the manual method is the recommended method. We sought to...
3.
Alghamdi M, Alqarawi W, Alharbi E, Balahmar R, Alruqi H, Jadu N, et al.
Circ Genom Precis Med
. 2024 Jul;
17(4):e004686.
PMID: 39069920
No abstract available.
4.
Almaghlouth I, Bohuliga K, Alanazi B, Alhawsa B, Alabdulkareem A, Alqarawi W, et al.
Lupus Sci Med
. 2024 May;
11(1).
PMID: 38789277
Objective: This study examined the prevalence of major adverse cardiovascular events (MACE) among Saudi patients with SLE and the general population and considered factors associated with such outcomes were taken...
5.
Alsaeed A, Al Kandari F, Sweidan R, Bokhari F, Al Fagih A, Almusaad A, et al.
Glob Heart
. 2024 Apr;
19(1):40.
PMID: 38681972
Background: Previous registries have shown a younger average age at presentation with cardiovascular diseases in the Middle East (ME), but no study has examined atrioventricular block (AVB). Moreover, these comparisons...
6.
Al-Bawardy R, Alqarawi W, Suwaidi J, Almahmeed W, Zubaid M, Amin H, et al.
Angiology
. 2024 Jan;
:33197241227025.
PMID: 38227549
The use of beta-blockers (BB) in reduced left ventricular ejection fraction (LVEF) post-myocardial infarction (MI) is associated with reduced 1-year mortality, while their role in patients with mid-range and preserved...
7.
Carrick R, De Marco C, Gasperetti A, Bosman L, Gourraud J, Trancuccio A, et al.
Eur Heart J
. 2024 Jan;
45(7):538-548.
PMID: 38195003
Background And Aims: Implantable cardioverter-defibrillators (ICDs) are critical for preventing sudden cardiac death (SCD) in arrhythmogenic right ventricular cardiomyopathy (ARVC). This study aims to identify cross-continental differences in utilization of...
8.
Alqarawi W, Tadros R, Roberts J, Cheung C, Green M, Burwash I, et al.
JACC Clin Electrophysiol
. 2023 Oct;
9(12):2494-2503.
PMID: 37804262
Background: There is growing evidence that mitral valve prolapse (MVP) is associated with otherwise unexplained cardiac arrest (UCA). However, reports are hindered by the absence of a systematic ascertainment of...
9.
Alsaeed A, Alqarawi W
Card Electrophysiol Clin
. 2023 Aug;
15(3):307-318.
PMID: 37558301
Unexplained cardiac arrest (UCA) is a working diagnosis that should be replaced by a final diagnosis once evaluation is completed. Complete evaluation of UCA should include high-yield tests like cardiac...
10.
Thibert M, Odabashian R, Lepage-Ratte M, Jones A, Alqarawi W, Nery P, et al.
Heart Rhythm
. 2023 Jul;
20(10):1418-1419.
PMID: 37468027
No abstract available.